2007, Consumption, Epilepsy and Terpenes

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2007

Consumption

Epilepsy

Terpenes

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

NOVEMBER 24, 2021

Chronic pain or pain were the conditions most frequently mentioned in articles about cannabis, followed by epilepsy, cancer or cancer pain, and nausea and chemotherapy. Refractory paediatric epilepsy. Conclusions. It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ).

Research and Development

Research and Development Medicine Access Media

Report: “Key pharmacological differences between side effects of refined, pharmaceutical CBD formulations and whole plant extracts:”

Cannabis Law Report

JULY 12, 2019

This differs sharply from the conventional course of cannabis medicine, which is to use whole, clean plant extracts to treat epilepsy and to gradually discontinue use of conventional pharmaceuticals. An Israeli study of cannabis versus epilepsy, however, used natural extracts with a ratio of 20:1 CBD:THC. Fig 1: Sucralose (In Study).

Extraction

Extraction Pharmaceutical CBD Epilepsy

Medical Cannabis Brief

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Report: “Key pharmacological differences between side effects of refined, pharmaceutical CBD formulations and whole plant extracts:”

Stay Connected